Topical Minoxidil: The Complete Guide to Solution, Foam and Spray

Topical minoxidil is a scalp treatment you apply directly to the skin, and Quintéa sells it in three different formats — Solution, Foam and Signature Spray — that share the same core active but differ in what else is mixed in, how irritating they tend to be, and how you apply them. Only one specific use is officially approved for the 5% products sold here: regrowing hair at the vertex, the crown of the scalp, in men. This guide sets out what that approval actually covers, how the three formats compare side by side, what a realistic timeline looks like, and the warnings worth reading before you start, then points you to the deeper articles for whichever format and question you want to follow up on.

• The FDA-approved use is narrow: regrowth at the vertex in men only. A receding hairline, the temples, a beard and use by women all sit outside that approval, which is why they're called off-label rather than unsupported.
• Solution and Foam carry the same 5% minoxidil concentration. The difference that changes how your scalp reacts is propylene glycol, an ingredient the Solution needs and the Foam leaves out.
• Signature Spray adds tretinoin, caffeine and melatonin to the minoxidil, so it's a distinct formulation with its own evidence and cautions, not a third way of delivering the same product.
• Some extra shedding in the first weeks is a normal part of the hair cycle resetting. Early signs of regrowth tend to appear around two to four months of consistent use, and stopping treatment lets any regained hair shed again within a few months.

What topical minoxidil is — and the one thing it's approved for

Minoxidil's exact route to regrowing hair still isn't fully mapped out, but the working explanation is that it prolongs the anagen, or growth, phase of the hair follicle, keeping more hairs in active growth for longer. Only a small fraction of an applied dose reaches the rest of the body — around 1.4% is absorbed systemically (source: PMC case report on topical minoxidil overdose).

For the 5% products sold here, the approved use is narrower than the way minoxidil is usually talked about. The FDA drug facts label states the use as regrowing hair "on the top of the scalp (vertex only)", and only for men (source: DailyMed drug facts label). A receding hairline, the temples, a beard, or use by a woman fall outside that approval.

Approved use vs. off-label use, in plain terms

Off-label doesn't mean untested or unsafe by definition; it means the manufacturer never sought, or the FDA never granted, approval for that specific use. A great many people apply minoxidil to a receding hairline or temples anyway, and the drug itself is identical to what's approved for the vertex. What changes is the strength of the evidence and the safety picture for that particular area, which is exactly what the hairline and temple treatment guide works through in detail. This guide states the boundary plainly and moves on, rather than treating off-label use as either endorsed or dismissed.

Solution, foam or spray: how the three formats actually differ

The Minoxidil Topical Solution measures out a precise 1 mL dose with a dropper, which you part your hair to place directly along the exposed rows of scalp. That precision is the point: it suits an area with a defined edge, such as the vertex margin, where you want the dose along a specific line rather than spread more broadly. The trade-off is propylene glycol, one of the inactive ingredients that carries the minoxidil into the skin and is also the ingredient most often behind the itching or dry, tight feeling some people get from the Solution.

The Minoxidil Topical Foam carries the same 5% concentration without the propylene glycol, and the irritation difference between the two shows up clearly in trial data: one review reports scalp irritation in roughly 7% of people on the 2% solution and more on the 5% solution, against a pruritus rate of just 1.1% with the 5% foam in a 352-man trial, compared with 6% seen in a separate 5% solution trial (source: Minoxidil Topical Foam: A New Kid on the Block). The same review found a 13.4% increase in target-area hair count with the 5% foam against 3.4% for placebo, which is the kind of efficacy data that lets the foam stand on its own rather than only as "the gentler option". For the buying details specific to this format, the foam buying guide goes further than a three-way comparison can.

Why the Signature Spray isn't just minoxidil in a spray bottle

The Signature Spray combines minoxidil 5% with tretinoin 0.01%, caffeine 0.2% and melatonin 0.1%, which makes it a compounded formula rather than a third container for the same single active. Tretinoin's role here is worth understanding rather than assuming: a narrative review found that applying tretinoin ahead of minoxidil increases minoxidil's absorption into the skin by close to threefold by making the skin more permeable, but the evidence for extra regrowth from that combination is mixed. One randomised trial found the two together performed similarly to minoxidil alone, and the review's conclusion is that dual therapy isn't supported as a first-line choice, only as a possible option for people who haven't responded to minoxidil by itself, weighed against the extra irritation that a more permeable scalp can bring (source: narrative review, tretinoin and minoxidil co-therapy). Caffeine and melatonin sit further down the evidence ladder again, closer to cosmetic support than a proven regrowth driver. None of that makes the Spray a poor choice; it means it deserves its own reasoning rather than being picked as "the strongest one".

Format	What's in it	How it's applied	Who it tends to suit
Solution	Minoxidil 5%, with propylene glycol and alcohol	1 mL by dropper, placed along partings, twice daily	Someone treating a defined edge, such as the vertex margin, who wants precise placement
Foam	Minoxidil 5%, no propylene glycol	Half a capful worked into the scalp, twice daily	Someone prone to itching or dryness from the Solution, or covering a broader area
Signature Spray	Minoxidil 5%, tretinoin 0.01%, caffeine 0.2%, melatonin 0.1%	Sprayed onto the scalp per the product directions, evaluated over a minimum of four months	Someone who has read the tretinoin trade-off and wants the compounded option rather than minoxidil alone

What to actually expect: shedding, timeline, and what happens if you stop

An increase in shedding during the first few weeks is a normal part of the hair cycle resetting rather than a sign the product isn't working, and it's also the point where a lot of people give up just before the treatment has had time to act. If you want the fuller mechanism behind why that happens, the shedding phase article covers it in more depth than a summary can.

Two timeframes get quoted for minoxidil, and they describe different stages rather than contradicting each other. The product's own label states that results "may take 2-4 months" of consistent twice-daily use, reflecting when early signs typically start to show. The American Academy of Dermatology frames full, noticeable results more broadly, at around six to twelve months (source: AAD, hair loss diagnosis and treatment) — the more realistic marker for the change you'd actually see in the mirror. The label treats the earlier window as a checkpoint rather than an open-ended wait: if there's still no visible regrowth after four months of consistent, twice-daily use, its guidance is to stop and talk to a doctor instead of continuing indefinitely on the assumption that more time will eventually work.

Response isn't uniform. Roughly four in ten men see moderate regrowth; others see little to none, and that variation is part of how the drug works rather than a sign of doing something wrong (source: American Hair Loss Association). Whatever level of regrowth you reach depends on continuing the treatment to keep it: stop, and any hair you've regained typically sheds again within three to four months, because minoxidil maintains a state rather than curing the underlying cause.

Side effects and who shouldn't use it

The common effects reported with topical minoxidil are dryness and redness of the scalp; dermatitis, itching, rash and hives develop less often, but they're the reactions worth watching for if your scalp doesn't settle after the first couple of weeks (source: Healio clinical guidance, topical minoxidil). A different set of signals means stopping and speaking to a doctor rather than waiting it out: chest pain, a rapid heartbeat, fainting, dizziness, sudden weight gain, swelling of the hands or feet, or hair growth showing up somewhere it wasn't meant to, most often the face. That last one is a sign the drug has reached skin beyond the treated area rather than a cosmetic side note, which is why the label lists it alongside the cardiac and swelling warnings rather than with the milder scalp irritation above.

The label sets out who shouldn't use the 5% products at all: women, anyone under 18, anyone whose hair loss is sudden or patchy, anyone with no identified cause for their hair loss, and anyone with a scalp that's red, infected, irritated or inflamed. Ask a doctor first if you're pregnant, breastfeeding, or have heart disease.

One safety detail that's easy to overlook because it has nothing to do with your own scalp: minoxidil residue is reported as severely toxic to cats through direct or shared-bedding contact, and unwanted hair growth in infants and small children has been linked to skin contact or shared pillows. That's a reasonable argument for letting the product dry fully, washing your hands after applying it, and keeping treated pillowcases away from pets and small children.

Getting more from whichever format you choose

Once the irritation profile and the way you apply a given format clearly fit your routine and the area you're treating, the linked product page for that format sets out the exact dosing and application steps. For a walkthrough that covers all three formats step by step in one place, the application guide is the next stop.

If you want an addition with genuine supporting evidence rather than a marketing add-on, weekly use of the Dermaroller alongside any of the three formats is the best-evidenced combination in the range, and it works on a beard as well as a scalp. One specific example worth naming rather than a vague "works better together" claim: a study cited by the AAD found that after 12 weeks, people using minoxidil together with weekly microneedling had significantly more hair growth than those using minoxidil alone (source: AAD, hair loss diagnosis and treatment).

A shampoo suited to your scalp has a real role here: keeping a treated scalp clean and comfortable makes the routine easier to stick with, though it isn't a way of growing hair on its own. If the alcohol and propylene glycol in the Solution leave your scalp uncomfortably dry between doses, that's a case for a moisturising step in your routine rather than a reason to stop treatment.

Two questions this guide deliberately leaves for other articles: how the actual trial evidence behind minoxidil holds up under scrutiny, which the efficacy evidence article covers in full, and whether you need a prescription for minoxidil where you live, which varies enough by country that the prescription-status article addresses it market by market rather than in general terms here.